全文获取类型
收费全文 | 16255篇 |
免费 | 1346篇 |
国内免费 | 230篇 |
专业分类
耳鼻咽喉 | 140篇 |
儿科学 | 580篇 |
妇产科学 | 3196篇 |
基础医学 | 1740篇 |
口腔科学 | 459篇 |
临床医学 | 1367篇 |
内科学 | 1710篇 |
皮肤病学 | 102篇 |
神经病学 | 122篇 |
特种医学 | 521篇 |
外国民族医学 | 4篇 |
外科学 | 1470篇 |
综合类 | 1901篇 |
现状与发展 | 3篇 |
预防医学 | 949篇 |
眼科学 | 89篇 |
药学 | 859篇 |
6篇 | |
中国医学 | 184篇 |
肿瘤学 | 2429篇 |
出版年
2024年 | 31篇 |
2023年 | 193篇 |
2022年 | 409篇 |
2021年 | 562篇 |
2020年 | 482篇 |
2019年 | 564篇 |
2018年 | 525篇 |
2017年 | 560篇 |
2016年 | 602篇 |
2015年 | 566篇 |
2014年 | 1103篇 |
2013年 | 1047篇 |
2012年 | 1005篇 |
2011年 | 1103篇 |
2010年 | 825篇 |
2009年 | 898篇 |
2008年 | 817篇 |
2007年 | 809篇 |
2006年 | 811篇 |
2005年 | 666篇 |
2004年 | 628篇 |
2003年 | 469篇 |
2002年 | 387篇 |
2001年 | 380篇 |
2000年 | 309篇 |
1999年 | 261篇 |
1998年 | 235篇 |
1997年 | 241篇 |
1996年 | 174篇 |
1995年 | 157篇 |
1994年 | 148篇 |
1993年 | 102篇 |
1992年 | 89篇 |
1991年 | 84篇 |
1990年 | 69篇 |
1989年 | 55篇 |
1988年 | 68篇 |
1987年 | 53篇 |
1986年 | 51篇 |
1985年 | 49篇 |
1984年 | 48篇 |
1983年 | 35篇 |
1982年 | 43篇 |
1981年 | 32篇 |
1980年 | 25篇 |
1979年 | 14篇 |
1978年 | 12篇 |
1977年 | 14篇 |
1976年 | 7篇 |
1973年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Journal of vascular and interventional radiology : JVIR》2020,31(7):1103-1109
PurposeTo explore the safety and effectiveness of bronchial artery (BA) embolization (BAE) in children with pulmonary hemorrhage.Materials and MethodsBetween February 2016 and February 2019, 41 patients (median age, 4 y; interquartile range, 2.3-8 y; median weight, 17.6 kg; interquartile range, 12.3–23.6 kg) underwent BAE. The indication of BAE included massive hemoptysis in 10 patients (24.4%), recurrent hemoptysis in 18 patients (43.9%), and refractory anemia in 13 patients (31.7%). The main etiology of pulmonary hemorrhage included pulmonary hemosiderosis (58.5%), congenital heart disease (17.1%), and infection (14.6%). A retrospective review was conducted of clinical outcomes of BAE.ResultsThere were 44 embolization sessions, with a total of 137 embolized vessels. Pulmonary hemorrhage was caused by BAs in 30 cases, nonbronchial systemic arteries plus BAs in 10, and nonbronchial systemic arteries in 1. Embolic particles were used in 30 cases (24 polyvinyl alcohol [PVA] and 6 microsphere), coils in 9 cases, and particles plus coils in 5 cases (4 PVA and 1 microsphere). Technical success (ability to embolize abnormal vessel) was achieved in 97.6% of patients (40 of 41), and clinical success (complete or partial resolution of hemoptysis within 30 days of embolization) was achieved in 90.2% (37 of 41). There was 1 procedure-related complication (2.4%) of cerebral infarction and 1 death from multiple-organ dysfunction (2.4%). Bleeding-free survival rates at 6, 12, 24, and 36 months were 92.5%, 83.9%, 83.9%, and 70.8%, respectively.ConclusionsBAE is a safe and effective procedure in children with pulmonary hemorrhage. 相似文献
2.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
3.
《Clínica e investigación en ginecología y obstetricia》2022,49(2):100721
Intravascular papillary endothelial hyperplasia or Masson's tumour is a non-neoplastic vascular lesion of reactive character. It is a rare diagnosis, clinically non-specific and with diverse locations. It is essential to take it into consideration and make a differential diagnosis with malignant vascular tumours such as angiosarcoma. Pathological study is fundamental for diagnosis. Treatment consists of complete resection of the tumour, including sufficiently wide margins to avoid recurrence.The case reported is an exceptional event, because of the pelvic location of the Masson's tumour that was diagnosed as part of the surgical staging of an ovarian cancer. 相似文献
4.
5.
Primary surgical prevention in the form of risk-reducing salpingo-oophorectomy (RRSO) is the most effective option and the gold standard for ovarian cancer (OC) risk-reduction, particularly given the absence of an effective national OC screening programme. However, premenopausal RRSO leads to premature surgical menopause with detrimental long-term health sequelae particularly in women who do not/are unable to take hormone replacement therapy (HRT). HRT uptake in women undergoing pre-menopausal oophorectomy appears low and is dependent on informed counselling, the safety of HRT and efficacy in mitigating the health sequelae of premature menopause. Acceptance of a central role for the fallopian tube in OC etiopathogenesis, coupled with the detrimental consequences of premature menopause, has led to the attractive proposal of early-salpingectomy with delayed oophorectomy as an alternative OC surgical prevention strategy in premenopausal women who have completed childbearing but decline or wish to delay RRSO. The successful implementation of risk reducing surgery for OC prevention depends on the acceptability of surgery to both, recipients (e.g. BRCA1/BRCA2 carriers) and intervention deliverers (healthcare professionals/researchers). Acceptability is also informed by an understanding of health outcomes following risk reducing surgery and the safety of HRT. It is therefore vital to understand the effects of surgery on important health outcomes such as cardiovascular health, neurological function and bone health. We present a comprehensive review of acceptability, the selected health outcomes mentioned above and HRT safety following risk reducing surgery. 相似文献
6.
本文报道了我院收治的卵巢恶性畸胎瘤31例,随访中2例失访,随访率为93.53%。并讨论了卵巢恶性畸瘤的治疗方式为手术加联合化疗,对年轻的I期患者可行患侧单侧附件切除术,术后化疗极为重要。化疗方法采用VAC或PVB方案联合化疗,本文还 影响预后的重要因素为临床分期期和病理学特点. 相似文献
7.
在 B 超引导下经皮穿刺囊内注射铝溶液治疗肾囊肿72例89个囊肿结果:消失48个,有效36个,总有效率94%。随访3个月至2年未见复发。其方法安全、简便、无副作用。并对铝溶液作用机制进行初步探讨。 相似文献
8.
本研究观察国产雌二醇周效贴片(E2贴片)治疗因卵巢功能低落所致的主要临床表现的疗效,结合血FSH、LH、E2测定,阴道脱落细胞成熟指数和部分病例的子宫内膜活检,对E2贴片的疗效进行了综合评价。结果显示,雌二醇周效贴片对卵巢功能低落所致的潮热、出汗、失眠、情绪波动,眩晕和阴道干涩等有显著疗效,且疗效随用药时间的延长而递增,在用药140天时总有效率分别达98.9%,92.0%、91.4%、90.0%和78.0%,对LH、FSH的释放有抑制作用;血清E2水平属轻度升高,但趋于平稳;部分病例子宫内膜组织学检查未见雌激素作用所致的内膜增殖效应。用药期间部分病例出现周期性阴道出血,这对年轻卵巢功能早哀者在生理和心理上均有治疗意义,但对更年期患者会造成不便和不安感。约20%的病例贴片局部有轻微痒感,无其它不良反应。 相似文献
9.
卵巢恶性肿瘤与血小板增多关系分析 总被引:1,自引:0,他引:1
李洁华 《中国现代医药杂志》2005,7(5):48-49
目的探讨卵巢恶性肿瘤伴发血小板增多的临床规律。方法回顾分析98例卵巢恶性肿瘤患者的临床资料,26例合并血小板增多。结果血小板增多占26.5%,其中晚期(Ⅲ+Ⅳ期)占88.46%,晚期患者血小板偏高明显增多,且肿瘤切除后血小板下降。结论卵巢恶性肿瘤伴发血小板增多晚期患者多见,预后差,血小板增多可作为判断卵巢肿瘤恶性程度及术后随访的指标。 相似文献
10.
胆道镜应用对肝胆胰术式选择的影响 总被引:1,自引:1,他引:0
目的 探讨分析胆道镜检查在肝胆胰疾患术式选择中的价值。方法 回顾分析1994~2004年收集术中或联合术后应用胆道镜治疗肝胆胰疾患2276例临床资料,进行分析及总结。结果 1966例肝胆管胆石患者胆道残留结石率从34.5%降至9.6%;82例术中胆道镜发现合并胆管狭窄,其中45例肝胆管膜状狭窄者在胆道镜指导下实施了有效扩张治疗;胆总管下段梗阻患者中224例肿瘤依据形态学检查,结合术中扪诊及活检组织学检查得到确诊,并采取了相应的手术方式。结论 胆道镜的应用有利于肝胆胰疾患术式的选择,可使一些较为复杂的胆道手术变得简单易行;对术前未能确诊的病变可以达到明确诊断并指导选择合理的术式。 相似文献